▲ Wall Street analysts forecast GILD to rise 15% over the next 12 months.
Avg Price Target
$158.71
+15.3% upside
According to Wall Street analysts, the average 12-month price target for Gilead Sciences, Inc. (GILD) is $158.71, implying +15.3% upside from the current price of $137.65.